Scholz Consulting Partners CLINICAL DIAGNOSTICS EXPERTS

Since 2005 · Boston, MA · USA & Japan

Clinical
Diagnostics
Expertise

Strategic consulting for precision oncology and clinical diagnostics companies, investors, and emerging technologies seeking market advantage.

20+
Years in Practice
>180
Projects Completed
3
Continents Served

We serve three client profiles

Strategic

Clinical diagnostics companies seeking market advantage and growth

Emerging

New technologies and products navigating the path to commercialization

Financial

Investors and financial institutions evaluating diagnostics opportunities

What We Do

Our Services

Biomarker Commercialization

Road maps from discovery to market. Product design, business and marketing plans for diagnostics assets.

Due Diligence

Business and technical assessment for investors. Rigorous evaluation of diagnostics assets and companies.

Licensing & Partnerships

Deal structuring, strategic alliances, and board advisory to accelerate business development.

Competitive Intelligence

Custom market and competitor analysis to inform strategy and uncover opportunity.

Japan Market Entry

Regulatory strategy, PMDA navigation, and commercial partnership development for the Japanese IVD market.

Interim Executive Roles

Implementation support, CEO/COO/VP BD capacity for companies requiring senior leadership bandwidth.

Technology Scouting

Identification of investment and partnership opportunities in diagnostics and precision medicine.

Product & Business Planning

Functional planning across disciplines: technical, clinical, regulatory, commercial, and financial.

How We Work

Strategic Approach

I

High-Level Assessment

Days to Weeks
  • Asset inventory & strength analysis
  • Objectives, market fit & competitive context
  • Initial opportunity conclusion
II

Detailed Plan Analysis

Weeks to Months
  • In-depth opportunity & competition assessment
  • Functional area plans across all disciplines
  • Risk identification & mitigation strategy
III

Execution & Support

Months to Years
  • Active implementation support
  • Advisory board participation
  • Optional interim executive management

Senior Consultants

The Team

Manfred Scholz

Manfred Scholz, PhD, MBA

Founder, President & CEO

SCP founder since 2005. Executive roles at Pillar Biosciences, Prolias (CEO), Stem Cell Preservation Technologies (President/COO), IQuum/Roche (VP BD), Large Scale Biology, and Dade Behring/Siemens.

Early career fellowships from Max-Planck-Society and Harvard University at MGH, Harvard Medical School, and Center for Blood Research. Published in oncology, infectious diseases, and in vivo imaging.

PhD Physics, JW Goethe-University Frankfurt · MBA, Babson College
Kazuhiro Matsumura

Kazuhiro (Mats) Matsumura

Country Manager, Japan

30+ years in IVD, life sciences, and analytical instrumentation. Representative Director & GM at Exact Sciences KK (Japan), leading Oncotype DX Breast RS commercialization in precision oncology.

Senior roles at Hitachi High-Tech including U.S. subsidiary President, driving global sales, M&A, and launches in clinical chemistry, microbiology, molecular diagnostics, DNA sequencing, and immunoassays. 10+ years international experience (Germany, U.S.).

Industrial Engineering, Aoyama Gakuin University, Tokyo
Heather Kiefer

Heather Kiefer, PhD

Senior Consultant, MDx, Research & Marketing

Hands-on molecular diagnostics development for infectious diseases at IntelligentMDx, progressing through Senior Scientist, Product Development Manager, and Marketing Manager roles encompassing market analysis, competitive intelligence, and technical writing.

Senior Science Analyst at Bioinformatics LLC; prior microbiology research at Nestlé R&D. Published in HIV and immunology.

PhD Microbiology, Boston University School of Medicine

Track Record

Selected Project Experience

Exit Deals

  • BioHelix → Quidel
  • ClarosDx → Opko Health
  • Anagnostec → bioMérieux
  • Prolias → Private acquirer

Due Diligence

  • Bayer · Biocartis
  • Dade Behring · ExosomeDx
  • IQuum · Ipsogen
  • MobiDiag · Nanosphere
  • T2 Bio

Business Plans

  • Alethus · BioHelix
  • ClarosDx · Imaemi
  • Pillar Biosciences · Prolias
  • SISCAPA · Biomarker Strategies

Implementation Leadership — Selected Engagements

Pillar Biosciences — Head of BD & CCO. Deals with Illumina, MGI, Columbia University, LabCorp, Thrive, PierianDx, Beckman Coulter, Hitachi High-Tech. Sales partnerships across US, ASEAN, South Korea, Israel, and Japan.

Prolias — CEO. License deals with Bio-Rad and Invitrogen/Life Technologies; led company to successful exit.

Get In Touch

Let's discuss your project

Whether you are evaluating a diagnostics asset, entering a new market, or need experienced leadership capacity, we are here to help.

Email
info(at)ScholzCP(dot)com
Phone
+1.617.418.1888
Address
54 Forest Street #323
Medford, MA 02155, USA
Website
www.ScholzCP.com